The North America cystoscopes market is expected to attain US$ 207.2 Mn in 2026.  Video cystoscopes market was identified as the largest and fastest growing market during the forecast period from 2018 to 2026. The supremacy is accounted to its offered benefits of enhanced diagnostic and treatment procedures. Requirement of skilled professionals and the need for procedures to be carried out in sterile environment primarily contribute to higher adoption of cystoscopes in hospitals and thereby to their largest share in North American market. Growing awareness of cystoscopes and its ease of use, accounts for rise in its demand among ambulatory care services leading to fastest growth rate during the forecast period. As reported by Photocure ASA (February 2018), 1.2 million cystoscopies are performed annually in the U.S. This value is further expected to increase during the forecast period owing to rising prevalence of bladder cancer, bladder stones, and cystitis. The growing prevalence of urologic conditions thus catalyzes the overall market growth in North America.

Conversely, sterility of cystoscopes is a major concern, which could have a negative impact on the overall market growth. Thus arises an unmet need of disposable cystoscopes to overcome the sterility issue, which will also mitigate the burden of urethral infections. However, various manufacturers currently provide cystoscopes with disposable endosheath protective barriers that ensure minimal patient-to-device contact avoiding contamination. Of the countries analyzed, U.S. accounted for maximum market share in 2017, and expected to continueits dominance throughout the forecast period. Growing prevalence of urinary disorders, increased healthcare expenditure, continuous product development activities, and presence of leading manufacturers namely, Cogentix Medical, Inc., Olympus Corporation and many more contribute to the overall market growth in the U.S.

"Video Cystoscopes to Maintain Supremacy throughout the Forecast Period"

Video cystoscopes accounted for maximum market share in 2017 and attained fastest growth rate during the forecast period from 2018 to 2026. This trend is followed by the growth of flexible non-video cystoscopes. The use of video cystoscopes increases the efficiency of diagnostic and therapeutic procedures thus augmenting their demand. On the other hand, flexible non-video cystoscopes are comparatively lower priced and their flexible nature ensures patient comfort and less painful procedure. Additionally, newer technologies namely, Blue Light Cystoscopy with Cysview enables enhanced diagnosis of cancerous cells. The Cysview (hexaminolevulinate HCl) gets absorbed by cancerous cells and glows pink under blue light. This development has further catalyzed the video cystoscopes market growth. Additionally, growing prevalence of bladder cancer, high patient awareness coupled with uniform product accessibility, minimally invasive technique and reduced procedural time benefits, contribute to the lucrativeness of video cystoscopes.

"Hospitals Contributed Maximum to the Overall North America Cystoscopes Market in 2017"

Hospitals segment accounted for maximum market share in 2017 and continues to dominate the market throughout the forecast period; while ambulatory care centers was identified as the fastest growing market during the forecast period from 2018 to 2026. Presence of skilled professionals, ease of availability of cystoscopy techniques, suitable reimbursement benefits, and high disposable incomes are the major factors for hospitals, significantly contribute to the overall cystoscopes market growth. Rising healthcare establishments and increasing benefits for health insurance companies primarily account for the fastest growth rate of ambulatory care services during the forecast period from 2018 to 2026. According to an article published on American College of Surgeons (FACS) (2017), a shift of outpatient procedures from hospitals to ambulatory care services would save US$ 25 Bn to Medicare over 10 years.

"United States Enjoyed Supremacy in 2017 and Expected to Continues this Trend Through 2026"

United States contributed the largest market share of above 72% in 2017 and shall exhibit similar dominance through 2026. Developed healthcare infrastructure, high disposable income of patients along with supportive reimbursement policies, awareness on new technologies in cystoscopy and rising prevalence of bladder cancer & kidney stones predominantly catalyze the overall U.S. cystoscopes market growth. According to the American Cancer Society, an estimated 81,190 new cases of urinary bladder cancer are expected to be diagnosed in 2018 with 17,240 expected deaths in the same year in the United States, making bladder cancer as the fourth common cancer in the country.

The Canadian Cancer Society estimated 8,900 Canadians diagnosed with bladder cancer in 2017. The growing prevalence of urologic disorders amongst Canadian population, rising awareness about benefits of cystoscopy and development of healthcare facilities contribute to the fastest CAGR during the forecast period from 2018 to 2026.

"North America Cystoscopes Market Renders Opportunities for New and Emerging Market Players"

North America cystoscopes market encompasses few market players enjoying prominence, namely Cogentix Medical, Inc. and Olympus Corporation. Market players like Olympus Corporation and Karl Storz GmbH & Co. KG have incorporated the new Blue Light Cystoscopy technology thus gaining a competitive edge in the market. Credence Research, Inc., expects that development in disposable cystoscopes similar to disposable endoscopes could gain additional market potential owing to better cost-efficiency and reduced risk of microbial contamination. This unmet need opens opportunities for emerging market players with advanced technologies.

Historical & Forecast Period

This report comprises analysis for every segment mentioned during the period from 2016 to 2026, considering 2017 as the base year. The compound annual growth rate for each segment is estimated for the forecast period from 2018 to 2026.

This report provides qualitative information for factors namely, market drivers, restraints & opportunities that would give a complete understanding of the prevalent scenario in North American cystoscopes market. Additionally, the report also includes graphical representation of competitive landscape depicting market position of key market leaders based on their market initiatives, product portfolio, financial information and business developments. Key market leaders profiled in this report are Cogentix Medical, Inc., Fujifilm Corporation, Karl Storz GmbH & Co. KG, Laborie Medical Technologies, Inc., Olympus Corporation, PENTAX Medical Company, Richard Wolf GmbH and Stryker Corporation.

Key questions answered in this report

• What are the current market trends in North America cystoscopes market?
• What is the market potential of Blue Light Cystoscopy in North America?
• What was the market share of hospitals to the overall North American cystoscopes market in 2017?
• What are the major reasons backing the expedited growth of ambulatory care services during the forecast period?
• What are the major drivers catalyzing the North America cystoscopes market growth?
• What percent of market share did video cystoscopes contribute in 2017?
• Which industry player enjoyed supremacy in 2017?
• Which country encompassed maximum market share in 2017?